<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0214544.ref019" class="ref">
 <label class="label">19</label>
 <mixed-citation publication-type="journal" class="mixed-citation">
  <name class="name">
   <surname class="surname">Khoo</surname>
   <given-names class="given-names">SM</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Humberstone</surname>
   <given-names class="given-names">AJ</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Porter</surname>
   <given-names class="given-names">CJH</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Edwards</surname>
   <given-names class="given-names">GA</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Charman</surname>
   <given-names class="given-names">WN</given-names>
  </name>. 
  <article-title class="article-title">Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine</article-title>. 
  <source class="source">Int J Pharm</source>. 
  <year class="year">1998</year>;
  <volume class="volume">167</volume>(
  <issue class="issue">1–2</issue>):
  <fpage class="fpage">155</fpage>–
  <lpage class="lpage">164</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1016/S0378-5173(98)00054-4</pub-id>
 </mixed-citation>
</ref>
